Results per Page:
Starting the year smarter
How patients, providers, researchers and others stay informed amid a deluge of data and information
Infectious disease experts propose trials network dedicated to immunocompromised patients
ImmunOptimize workshop convened stakeholders across disciplines to brainstorm infectious disease clinical trials network designed to serve people with weakened immune systems
The exclusion of immunocompromised patients in clinical trials and how we can do better
From Drs. Michael Boeckh, Joshua Hill, Steven Pergam and Larry Corey, Hematologic Malignancies and Cancer Immunology Programs of the Cancer Consortium
In the crosshairs: herpesvirus 6B as a potential cause of idiopathic pneumonia
From the Hill and Boeckh groups, Vaccine and Infectious Disease and Clinical Research Divisions
Investigating CMV reactivation in CARTx patients reveals high risk patients
From the Hill lab, Vaccine and Infectious Disease, Clinical Research and Translational Sciences and Therapeutics Divisions
National study recommends starting SARS-CoV-2 mRNA vaccination three months after bone marrow transplant
Study involving 22 U.S. cancer centers and research institutions is one of the largest analyses of vaccination for any pathogen within the first year after bone marrow transplant
Infectious disease scientists look beyond the pandemic
A symposium about protecting people with weakened immune systems from microbial threats
Work smarter not harder: Leveraging cancer immunotherapies to improve organ transplantation
From the Hill Group, Vaccine and Infectious Disease and Clinical Research Divisions
How blood cancer research might help organ transplant patients
Fred Hutch study suggests certain immune cells are source of antibodies that attack donated organs
Science Says: Back to the future
Navigating work, school, and well-being in a world transformed by COVID-19
Tip Sheet: Cancer-busting broccoli sprout pills in space, trauma and healing among Indigenous people, how to boost HPV vaccinations
Summaries of recent Fred Hutch research findings and other news
Cancer patients and the COVID-19 vaccines
Clinicians, cancer patients and coronavirus researchers weigh in on vaccination safety, timing, allergy concerns and more
How COVID-19 has opened science
An urgent search for answers promotes a faster, freer exchange of ideas
Antiviral immunity survives CD19-directed therapy
From the Hill and Turtle laboratories, Vaccine and Infections Disease Division and Clinical Research Division
Does CAR T-cell therapy leave patients vulnerable to infection?
$3.3M Cancer Moonshot grant to study how immunotherapy impacts patients’ ability to fight off bugs
Infections in immune-compromised patients: 5 new frontiers
Infectious disease experts gather in Seattle to find solutions for patients with compromised immunity